Nkcfo LLC Abb Vie Inc. Transaction History

Nkcfo LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	BUY	$138.31 - $165.87 $20,746 - $24,880	150 Added 20.41%	885 $143,000
Q2 2022 Jul 08, 2022	BUY	$137.62 - $174.96 $20,643 - $26,244	150 Added 25.64%	735 $113,000
Q1 2022 Apr 28, 2022	BUY	$131.98 - $163.75 $77,208 - $95,793	585 New	585 $95,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Nkcfo LLC, based on Form 13F filings with the SEC.

Stay updated on Nkcfo LLC with notifications on news.